$SKIN
Beauty Health Co

2022 Q2 Form 10-Q Financial Statement

#000181809322000072 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $103.5M $75.42M $77.89M
YoY Change 55.67% 58.63%
Cost Of Revenue $31.88M $23.48M $21.13M
YoY Change 65.56% 48.58% -59.29%
Gross Profit $71.65M $51.94M $56.76M
YoY Change 51.65% 63.63% -15.53%
Gross Profit Margin 69.21% 68.87% 72.87%
Selling, General & Admin $69.79M $62.67M $58.77M
YoY Change -1.17% 124.57% -27.45%
% of Gross Profit 97.4% 120.66% 103.53%
Research & Development $2.601M $2.230M $1.875M
YoY Change -12.95% 53.58% -44.85%
% of Gross Profit 3.63% 4.29% 3.3%
Depreciation & Amortization $4.590M $1.416M $9.349M
YoY Change 555.71% 105.22% -35.08%
% of Gross Profit 6.41% 2.73% 16.47%
Operating Expenses $75.07M $64.90M $63.97M
YoY Change 1.99% 121.06% 5187.02%
Operating Profit -$3.413M -$12.96M -$7.212M
YoY Change -87.05% -644.12% -110.93%
Interest Expense -$5.423M -$3.400M -$2.894M
YoY Change 163.25% -40.34% -2994.0%
% of Operating Profit
Other Income/Expense, Net $16.84M $48.08M -$6.142M
YoY Change -114.66% -906.49%
Pretax Income $8.007M $35.12M -$16.25M
YoY Change -105.67% -1081.06% 1363.78%
Income Tax $76.00K $2.600M $1.063M
% Of Pretax Income 0.95% 7.4%
Net Earnings $7.931M $32.51M -$17.31M
YoY Change -105.69% -1092.88% 1459.55%
Net Earnings / Revenue 7.66% 43.1% -22.23%
Basic Earnings Per Share $0.04 $0.22
Diluted Earnings Per Share $52.27K -$0.13 -$117.9K
COMMON SHARES
Basic Shares Outstanding 150.6M shares 150.6M shares 149.6M shares
Diluted Shares Outstanding 151.7M shares 152.7M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $821.0M $859.2M $901.9M
YoY Change 709.1% 31109.23% 27229.88%
Cash & Equivalents $821.0M $859.2M $901.9M
Short-Term Investments
Other Short-Term Assets $20.34M $13.55M $12.32M
YoY Change 323.31% 2175.73% 1953.67%
Inventory $73.53M $47.03M $35.26M
Prepaid Expenses
Receivables $79.92M $60.77M $46.82M
Other Receivables $1.008M $1.801M $4.599M
Total Short-Term Assets $995.8M $982.4M $1.001B
YoY Change 470.83% 29236.2% 1593.7%
LONG-TERM ASSETS
Property, Plant & Equipment $33.83M $32.11M $31.18M
YoY Change 234.54% 239.19%
Goodwill $123.8M $123.7M
YoY Change 25.61% 25.54%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.14M $8.026M $6.705M
YoY Change 307.19% 39.31%
Total Long-Term Assets $219.2M $216.8M $217.9M
YoY Change 30.42% -52.89% 33.09%
TOTAL ASSETS
Total Short-Term Assets $995.8M $982.4M $1.001B
Total Long-Term Assets $219.2M $216.8M $217.9M
Total Assets $1.215B $1.199B $1.219B
YoY Change 254.72% 158.7% 446.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $36.83M $26.96M $29.05M
YoY Change 112.55% 57.15%
Accrued Expenses $47.72M $12.42M $14.72M
YoY Change 122.98% 1449.43% 498.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $87.06M $68.93M $76.44M
YoY Change 120.44% 8373.57% 147.13%
LONG-TERM LIABILITIES
Long-Term Debt $732.0M $731.0M $729.9M
YoY Change
Other Long-Term Liabilities $39.70M $11.00K $0.00
YoY Change 2146.46% -99.98% -100.0%
Total Long-Term Liabilities $771.7M $11.00K $0.00
YoY Change 43574.19% -99.98% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.06M $68.93M $76.44M
Total Long-Term Liabilities $771.7M $11.00K $0.00
Total Liabilities $862.6M $857.5M $916.5M
YoY Change 164.25% 1153.49% 262.55%
SHAREHOLDERS EQUITY
Retained Earnings -$386.2M -$418.7M
YoY Change 467.81% 860.26%
Common Stock $16.00K $16.00K
YoY Change 300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $352.3M $341.7M $302.3M
YoY Change
Total Liabilities & Shareholders Equity $1.215B $1.199B $1.219B
YoY Change 254.72% 158.7% 446.95%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $7.931M $32.51M -$17.31M
YoY Change -105.69% -1092.88% 1459.55%
Depreciation, Depletion And Amortization $4.590M $1.416M $9.349M
YoY Change 555.71% 105.22% -35.08%
Cash From Operating Activities -$31.34M -$38.47M $3.279M
YoY Change -0.29% -3150.83% -400.83%
INVESTING ACTIVITIES
Capital Expenditures -$3.404M $3.149M -$8.530M
YoY Change -31.65% 284.96% -323.3%
Acquisitions
YoY Change
Other Investing Activities -$1.475M $0.00
YoY Change -64.36% -100.0%
Cash From Investing Activities -$4.879M -$3.425M -$8.530M
YoY Change -46.5% 246.66% -98.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.980M -$783.0K 188.2M
YoY Change -101.49% -117.89% -59.47%
NET CHANGE
Cash From Operating Activities -31.34M -$38.47M 3.279M
Cash From Investing Activities -4.879M -$3.425M -8.530M
Cash From Financing Activities -1.980M -$783.0K 188.2M
Net Change In Cash -38.19M -$42.68M 183.0M
YoY Change -141.29% -1017.83% 5546.88%
FREE CASH FLOW
Cash From Operating Activities -$31.34M -$38.47M $3.279M
Capital Expenditures -$3.404M $3.149M -$8.530M
Free Cash Flow -$27.93M -$41.62M $11.81M
YoY Change 5.61% -9495.03% -340.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001818093
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39565
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
The Beauty Health Company
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1908962
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2165 Spring Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Long Beach
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90806
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60769000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46824000 USD
CY2022Q1 dei City Area Code
CityAreaCode
800
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
603-4996
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
SKIN
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150631965 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
859237000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901886000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2536000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2681000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
982394000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13554000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12322000 USD
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1801000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4599000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
47033000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
35261000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1000892000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
17859000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
16183000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14251000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14992000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52544000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56010000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
123774000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
123694000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
330000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
330000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8026000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6705000 USD
CY2022Q1 us-gaap Assets
Assets
1199178000 USD
CY2021Q4 us-gaap Assets
Assets
1218806000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
26962000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29049000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21383000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28662000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12419000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14722000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3969000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3712000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4197000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
292000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
68930000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
76437000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12032000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12781000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3761000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3561000 USD
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
41765000 USD
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
93816000 USD
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
730971000 USD
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
729914000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
857470000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
916509000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150603231 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150603231 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150598047 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150598047 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
729299000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
722250000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1402000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1257000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-386205000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-418712000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
341708000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
302297000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1199178000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1218806000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75415000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47542000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
23478000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
15802000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
51937000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
31740000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36407000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17095000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2230000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1452000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26261000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10811000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
64898000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
29358000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12961000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2382000 USD
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3400000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5699000 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-52052000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
368000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-937000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-256000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
48083000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5962000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35122000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3580000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2615000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-306000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
32507000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3274000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-145000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32362000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3279000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150598105 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35501743 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152711698 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35501743 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29960000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3274000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-33205000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
302297000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7049000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
32507000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-145000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
341708000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
32507000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3274000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
1416000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
690000 USD
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
404000 USD
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
229000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1055000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3174000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2921000 USD
CY2022Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
135000 USD
CY2021Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
33000 USD
CY2022Q1 skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
0 USD
CY2021Q1 skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
394000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7049000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
34000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-829000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
2182000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-842000 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-52052000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1057000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14152000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8457000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2052000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
975000 USD
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3342000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-217000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11875000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1411000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1587000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1182000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2664000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3067000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8252000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5018000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
11000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-81000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-954000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3909000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
86000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38471000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1261000 USD
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
276000 USD
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
170000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3149000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
818000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3425000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-988000 USD
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
783000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
5000000 USD
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
443000 USD
CY2022Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 USD
CY2021Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
180000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-783000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4377000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-42679000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4650000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-21000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
901886000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9486000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
859237000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14115000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5130000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
3123000 USD
CY2021Q2 skin Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
368000000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-3645000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
647000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
863000 USD
CY2022Q1 skin Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction
DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2021Q1 skin Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction
DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction
2203000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 skin Common Stock Convertible Conversion Ratio
CommonStockConvertibleConversionRatio
1
CY2021Q2 skin Reverse Recapitalization Consideration Received
ReverseRecapitalizationConsiderationReceived
783000000 USD
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
350000000 USD
CY2021Q2 skin Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
433000000 USD
CY2021Q2 skin Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
57000000 USD
CY2021Q2 skin Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35501743 shares
CY2021Q2 skin Reverse Recapitalization Cash Paid For Working Capital Adjustments
ReverseRecapitalizationCashPaidForWorkingCapitalAdjustments
900000 USD
CY2021Q2 skin Stock Issued During Period Shares Reverse Recapitalization Working Capital Adjustment
StockIssuedDuringPeriodSharesReverseRecapitalizationWorkingCapitalAdjustment
70860 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75415000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47542000 USD
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14723000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12024000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
32310000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23237000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
47033000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
35261000 USD
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7482000 USD
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
15262000 USD
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1805000 USD
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
922000 USD
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4573000 USD
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3022000 USD
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7523000 USD
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
9456000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21383000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28662000 USD
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4356000 USD
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5817000 USD
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2786000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
783000 USD
CY2022Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
2124000 USD
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
2153000 USD
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
840000 USD
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1074000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5099000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2109000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12419000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14722000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
9803000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
8561000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
17859000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
16183000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
1416000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
690000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
112568000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
60024000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52544000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
112299000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56289000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56010000 USD
CY2022Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3174000 USD
CY2021Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2921000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
123694000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
98531000 USD
CY2022Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
174000 USD
CY2021Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0 USD
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-94000 USD
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
4000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
123774000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
98535000 USD
CY2021Q3 skin Debt Instrument Debt Default Default Interest Rate Maximum
DebtInstrumentDebtDefaultDefaultInterestRateMaximum
0.0100
CY2021 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2300000 USD
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2000000 USD
CY2021Q1 skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
400000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2600000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0745
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0855
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7049000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11500000 shares
CY2021Q2 skin Reverse Recapitalization Lock Up Agreement No Trade Period
ReverseRecapitalizationLockUpAgreementNoTradePeriod
P180D
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 skin Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150603231 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150603231 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150598047 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150598047 shares
CY2022Q1 skin Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75415000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47542000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32507000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3274000 USD
CY2022Q1 skin Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount
52052000 USD
CY2021Q1 skin Warrant Down Round Feature Decrease In Net Income To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeToCommonShareholderAmount
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19545000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3274000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150598105 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35501743 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2113593 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152711698 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35501743 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09

Files In Submission

Name View Source Status
0001818093-22-000072-index-headers.html Edgar Link pending
0001818093-22-000072-index.html Edgar Link pending
0001818093-22-000072.txt Edgar Link pending
0001818093-22-000072-xbrl.zip Edgar Link pending
ex311-202210q.htm Edgar Link pending
ex312-202210q.htm Edgar Link pending
ex321-202210q.htm Edgar Link pending
ex322-202210q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skin-20220331.htm Edgar Link pending
skin-20220331.xsd Edgar Link pending
skin-20220331_cal.xml Edgar Link unprocessable
skin-20220331_def.xml Edgar Link unprocessable
skin-20220331_htm.xml Edgar Link completed
skin-20220331_lab.xml Edgar Link unprocessable
skin-20220331_pre.xml Edgar Link unprocessable